Russell Investments Group’s Intersect ENT, Inc XENT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-19,749
| Closed | -$553K | – | 3019 |
|
|
2022
Q1 | $553K | Sell |
19,749
-12,738
| -39% | -$349K | ﹤0.01% | 2189 |
|
|
2021
Q4 | $887K | Sell |
32,487
-12,485
| -28% | -$338K | ﹤0.01% | 2207 |
|
|
2021
Q3 | $1.22M | Buy |
44,972
+11,718
| +35% | +$290K | ﹤0.01% | 2095 |
|
|
2021
Q2 | $568K | Sell |
33,254
-44,735
| -57% | -$837K | ﹤0.01% | 2541 |
|
|
2021
Q1 | $1.63M | Sell |
77,989
-20,989
| -21% | -$484K | ﹤0.01% | 1997 |
|
|
2020
Q4 | $2.27M | Sell |
98,978
-8,374
| -8% | -$159K | ﹤0.01% | 1692 |
|
|
2020
Q3 | $1.75M | Buy |
107,352
+22,161
| +26% | +$401K | ﹤0.01% | 1766 |
|
|
2020
Q2 | $1.15M | Buy |
85,191
+32,616
| +62% | +$379K | ﹤0.01% | 1971 |
|
|
2020
Q1 | $622K | Buy |
+52,575
| New | +$1.17M | ﹤0.01% | 2080 |
|
|
2019
Q3 | – | Sell |
-11,851
| Closed | -$269K | – | 3128 |
|
|
2019
Q2 | $269K | Sell |
11,851
-15,943
| -57% | -$430K | ﹤0.01% | 2448 |
|
|
2019
Q1 | $893K | Sell |
27,794
-21,867
| -44% | -$677K | ﹤0.01% | 2130 |
|
|
2018
Q4 | $1.4M | Buy |
49,661
+253
| +0.5% | +$7.41K | ﹤0.01% | 1770 |
|
|
2018
Q3 | $1.42M | Buy |
49,408
+7,589
| +18% | +$228K | ﹤0.01% | 1930 |
|
|
2018
Q2 | $1.57M | Sell |
41,819
-8,678
| -17% | -$341K | ﹤0.01% | 1884 |
|
|
2018
Q1 | $1.98M | Buy |
50,497
+17,933
| +55% | +$655K | ﹤0.01% | 1846 |
|
|
2017
Q4 | $1.07M | Sell |
32,564
-12,751
| -28% | -$382K | ﹤0.01% | 2127 |
|
|
2017
Q3 | $1.41M | Buy |
45,315
+7,101
| +19% | +$210K | ﹤0.01% | 1966 |
|
|
2017
Q2 | $1.07M | Buy |
38,214
+3,090
| +9% | +$70K | ﹤0.01% | 2080 |
|
|
2017
Q1 | $602K | Buy |
35,124
+3,594
| +11% | +$50.3K | ﹤0.01% | 2351 |
|
|
2016
Q4 | $377K | Buy |
+31,530
| New | +$408K | ﹤0.01% | 2554 |
|
Russell Investments Group's XENT Position: Q2 2022 in Review
Russell Investments Group sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 19,749 shares — an estimated $553K sold.
Russell Investments Group first reported a position in XENT in Q4 2016 and held it in 20 quarters. The position peaked at $2.27M in Q4 2020. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.
- Russell Investments Group reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
- Russell Investments Group sold 19,749 Intersect ENT, Inc shares in Q2 2022, an estimated $553K.
- Russell Investments Group first reported a position in Intersect ENT, Inc in Q4 2016 and held it in 20 quarters.
- Russell Investments Group's Intersect ENT, Inc position peaked at $2.27M in Q4 2020.
- 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.
Based on Russell Investments Group's 13F filing for Q2 2022, filed 29 Jul 2022.